Cargando…

α-hederin overcomes hypoxia-mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway

Currently, chemoresistance is a major challenge that directly affects the prognosis of patients with colorectal cancer (CRC). In addition, hypoxia is associated with poor prognosis and therapeutic resistance in patients with cancer. Accumulating evidence has shown that α-hederin has significant anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jinbao, Xu, Jian, Yang, Jiahua, Zhan, Yueping, Li, Sen, Jia, Linlin, Wu, Wentao, Si, Xianke, Zhang, Die, Yu, Kun, Yin, Peihao, Cao, Yijun, Deng, Wanli, Xu, Ke, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911077/ https://www.ncbi.nlm.nih.gov/pubmed/36704835 http://dx.doi.org/10.3892/ijo.2023.5481

Ejemplares similares

Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer
por: Chen, Jinbao, et al.
Publicado: (2021)

Synthesis and Tumor Cytotoxicity of Novel Amide Derivatives of β-Hederin
por: Liu, Yang, et al.
Publicado: (2010)

D Rhamnose β-Hederin against human breast cancer by reducing tumor-derived exosomes
por: Chen, Wei-Xian, et al.
Publicado: (2018)

Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
por: Ritter, Violetta, et al.
Publicado: (2021)

Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
por: Yuan, Zeting, et al.
Publicado: (2020)

Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
por: Ritter, Violetta, et al.
Publicado: (2022)

α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Hippo-Yes-Associated Protein Signaling Pathway
por: Chen, Tongqing, et al.
Publicado: (2022)

d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission
por: Chen, Wei-xian, et al.
Publicado: (2018)

α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
por: Zeng, Junan, et al.
Publicado: (2023)

Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells
por: Li, Jiao, et al.
Publicado: (2018)

Alpha-Hederin, the Active Saponin of Nigella sativa, as an Anticancer Agent Inducing Apoptosis in the SKOV-3 Cell Line
por: Adamska, Anna, et al.
Publicado: (2019)

α-Hederin Increases The Apoptosis Of Cisplatin-Resistant Gastric Cancer Cells By Activating Mitochondrial Pathway In Vivo And Vitro
por: Liu, Yinghui, et al.
Publicado: (2019)

The Novel Autophagy Inhibitor Alpha-Hederin Promoted Paclitaxel Cytotoxicity by Increasing Reactive Oxygen Species Accumulation in Non-Small Cell Lung Cancer Cells
por: Zhan, Yujuan, et al.
Publicado: (2018)

The Apoptotic Effect of D Rhamnose β-Hederin, a Novel Oleanane-Type Triterpenoid Saponin on Breast Cancer Cells
por: Cheng, Lin, et al.
Publicado: (2014)

Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
por: Xu, Xi, et al.
Publicado: (2023)

α-Hederin Arrests Cell Cycle at G2/M Checkpoint and Promotes Mitochondrial Apoptosis by Blocking Nuclear Factor-κB Signaling in Colon Cancer Cells
por: Sun, Dongdong, et al.
Publicado: (2018)

α-Hederin inhibits the growth of lung cancer A549 cells in vitro and in vivo by decreasing SIRT6 dependent glycolysis
por: Fang, Cong, et al.
Publicado: (2020)

Overexpression of adrenomedullin protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis via the Akt/GSK3β and Bcl-2 signaling pathways
por: Si, Hongjin, et al.
Publicado: (2018)

α-Hederin Saponin Augments the Chemopreventive Effect of Cisplatin against Ehrlich Tumors and Bioinformatic Approach Identifying the Role of SDF1/CXCR4/p-AKT-1/NFκB Signaling
por: Elaidy, Samah M., et al.
Publicado: (2023)

CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells
por: Zhu, Rong, et al.
Publicado: (2015)

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
por: García-Aranda, Marilina, et al.
Publicado: (2018)

Tissue adhesive indocyanine green‐locking granular gel‐mediated photothermal therapy combined with checkpoint inhibitor for preventing postsurgical recurrence and metastasis of colorectal cancer
por: Zeting, Yuan, et al.
Publicado: (2023)

Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway
por: Zhang, Ye, et al.
Publicado: (2021)

α-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation
por: Sun, Jian, et al.
Publicado: (2019)

Overcoming Resistance to AC0010, a Third Generation of EGFR Inhibitor, by Targeting c-MET and BCL-2
por: Xu, Wanhong, et al.
Publicado: (2018)

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
por: Choudhary, G S, et al.
Publicado: (2015)

Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
por: Zhan, Yueping, et al.
Publicado: (2020)

miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2
por: Li, Qingguo, et al.
Publicado: (2016)

Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
por: Kapoor, Isha, et al.
Publicado: (2020)

Unmasking BCL-2 Addiction in Synovial Sarcoma by Overcoming Low NOXA
por: Fairchild, Carter K., et al.
Publicado: (2021)

Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
por: Rooswinkel, R W, et al.
Publicado: (2012)

Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
por: Yue, XiaoYan, et al.
Publicado: (2020)

Effect of Alpha-Hederin, the active constituent of Nigella sativa, on miRNA-126, IL-13 mRNA levels and inflammation of lungs in ovalbumin-sensitized male rats
por: Fallahi, Maryam, et al.
Publicado: (2016)

Valproic acid overcomes hypoxia-induced resistance to apoptosis
por: CIPRO, ŠIMON, et al.
Publicado: (2011)

Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
por: Elming, Pernille B., et al.
Publicado: (2019)

Overcoming hypoxia-induced functional suppression of NK cells
por: Solocinski, Kristen, et al.
Publicado: (2020)

Inhibition of Bcl-xL overcomes polyploidy resistance and leads to apoptotic cell death in acute myeloid leukemia cells
por: Zhou, Weihua, et al.
Publicado: (2015)

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments
por: Mukherjee, Nabanita, et al.
Publicado: (2016)

SAT-008 Overcoming BCL-2 Resistance in Glucocorticoid-Treated Tumor Lymphoid Cells
por: Bortner, Carl, et al.
Publicado: (2019)

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer
por: Lopez, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cl9h1s7rfk40qmr2lqim0vm08g